Thread Reader
Share this page!
×
Post
Share
Email
Enter URL or ID to Unroll
×
Unroll Thread
You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649
How to get URL link on X (Twitter) App
On the Twitter thread, click on
or
icon on the bottom
Click again on
or
Share Via icon
Click on
Copy Link to Tweet
Paste it above and click "Unroll Thread"!
More info at
Twitter Help
Sam Klempner
@KlempnerSam
GI medical oncologist focusing on stomach and esophageal cancer research at Massachusetts General Hospital, Harvard Medical School
Subscribe
Save as PDF
Dec 7, 2022
•
21 tweets
•
112 min read
@TumorBoardTues
1/15
#TumorBoardTuesday
#GastricCancer
#OncTwitter
Here goes
🎬Starting out with an overall poll Q
When a new advanced GC/GEJ patient presents to your clinic, your institution reflexively tests for which of the following?
@TumorBoardTues
2/15
#TumorBoardTuesday
68y/o with poorly diff gastric cardia adeno, diffuse LAD, +peritoneal mets.
🧬Biomarkers HER2-, PD-L1-, MSS
🧪Pre-screened for trials & FGFR2b-, Claudin18.2+
🔦Enrolls in frontline SPOTLIGHT trial.
❓What is Claudin18.2?
❓What is SPOTLIGHT?
Save as PDF
Oct 27, 2021
•
15 tweets
•
104 min read
@MPishvaian
@TumorBoardTues
@SalemGIOncDoc
@YJanjigianMD
@DocCatenacci
@rachnatshroff
@gabe_a_brooks
@sonbol_bassam
@JoeChaoMD
@JohnEbbenMDPhD
2/13
#TumorBoardTuesday
Starts on FLOT. C2 c/b😴, neutropenia, LFT ⬆️.
Unplanned CT with🙅🏼♂️👎response, hard to separate mass from liver capsule (not metastatic).
MDC feels risk of R1 resection, but resectable. MMR testing, complete PMS2 & MLH1 loss
@MPishvaian
@TumorBoardTues
@SalemGIOncDoc
@YJanjigianMD
@DocCatenacci
@rachnatshroff
@gabe_a_brooks
@sonbol_bassam
@JoeChaoMD
@JohnEbbenMDPhD
@LFerri123
@MarkarSheraz
@doctorC369